Teaima, M.H.; Helal, D.A.; Alsofany, J.M.; El-Nabarawi, M.A.; Yasser, M.
Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. Pharmaceutics 2022, 14, 2405.
https://doi.org/10.3390/pharmaceutics14112405
AMA Style
Teaima MH, Helal DA, Alsofany JM, El-Nabarawi MA, Yasser M.
Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. Pharmaceutics. 2022; 14(11):2405.
https://doi.org/10.3390/pharmaceutics14112405
Chicago/Turabian Style
Teaima, Mahmoud H., Doaa A. Helal, Jihad M. Alsofany, Mohamed A. El-Nabarawi, and Mohamed Yasser.
2022. "Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal" Pharmaceutics 14, no. 11: 2405.
https://doi.org/10.3390/pharmaceutics14112405
APA Style
Teaima, M. H., Helal, D. A., Alsofany, J. M., El-Nabarawi, M. A., & Yasser, M.
(2022). Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. Pharmaceutics, 14(11), 2405.
https://doi.org/10.3390/pharmaceutics14112405